Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria

Royal Melbourne Hospital (RMH), Melbourne

The Wesley Hospital, Brisbane

Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH), New York

Charite - Universitaetsmedizin Berlin, Berlin

University of Washington-Seattle Cancer Care Alliance, Seattle

Thomas Jefferson University, Philadelphia

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milan

Wake Forest University Baptist Health, Winston-Salem

Hospital Universitario 12 de Octubre, Madrid

University Of Miami School Of Medicine, Center For Liver Diseases, Miami

U.O.C. Medicina Interna Azienda ospedaliero Universitaria Policlinico di Modena, Modena

Remington-Davis Clinical Research, Columbus

Westfaelische Wilhelms-Universitaet Muenster, Münster

Kansas City Research Institute, Kansas City

The University of Texas Medical Branch (UTMB), Galveston

Marvel Clinical Research, LLC, Huntington Beach

MetroBoston Clinical Partners, LLC, Brighton

University of Alberta, Edmonton

Azienda Ospedaliera Spedali Civili di Brescia-Universita degli Studi Di Brescia, Brescia

I.F.O Hospital Centro Porfirie e Malattie Rare, Rome

Kobe University Hospital, Kobe

Investigator site, Sayama

Osaka Medical College Hospital, Takatsuki

Tokyo Saiseikai Central Hospital, Minato-ku

Haukeland University Hospital, Bergen

Sophia Dermatology Clinic, Kanazawa

Toyama University Hospital, Sugitani

Hospital Clínic de Barcelona, Barcelona

Karolinska University Hospital, Stockholm

University of Manchester, Salford

Evelina London Children's Hospital - Guy's & St Thomas' NHS Foundation Trust, London